Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Very early researchLooking for participantsNCT07000682
What this trial is testing

The Clinical Study on the Treatment of SSc With UTAA91 Injection.

Who this might be right for
Systemic Sclerosis (SSc)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Testing effectiveness (Phase 2)Looking for participantsNCT06685042
What this trial is testing

Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases

Who this might be right for
Lupus Erythematosus, SystemicSystem; SclerosisANCA Associated Vasculitis+2 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 8
Not applicableStudy completedNCT00958672
What this trial is testing

Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule Endoscopy

Who this might be right for
Systemic Sclerosis
University Hospital, Rouen 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07493395
What this trial is testing

Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

Who this might be right for
Scleroderma, Systemic
University Hospital, Montpellier 6
Not applicableStudy completedNCT00213525
What this trial is testing

Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls

Who this might be right for
Scleroderma
University Hospital, Rouen 300
Not applicableEnrolling By InvitationNCT06847750
What this trial is testing

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

Who this might be right for
Scleroderma
The Hospital for Sick Children 20
Not applicableStudy completedNCT04325217
What this trial is testing

Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 586
Very early researchNot Yet RecruitingNCT07697274
What this trial is testing

Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial

Who this might be right for
Systemic SclerosisSclerodactyly
Medical University of South Carolina 10
Not applicableNot Yet RecruitingNCT07393217
What this trial is testing

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)
Sohag University 111
Not applicableStudy completedNCT04223817
What this trial is testing

7.0 Tesla Resonance Magnetic Imaging of the Hand in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Magnetic Resonance Imaging (MRI)
Poitiers University Hospital 50
Not applicableStudy completedNCT03644225
What this trial is testing

Suction Based Characterization of Healthy and Diseased Skin

Who this might be right for
Systemic Sclerosis
Oliver Distler 67
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Testing effectiveness (Phase 2)Study completedNCT04200755
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma

Who this might be right for
Localized Scleroderma
University of Cologne 45
Not applicableNo Longer AvailableNCT01374282
What this trial is testing

Post Marketing Surveillance Study of Cuprimine

Who this might be right for
Scleroderma
Merck Sharp & Dohme LLC
Not applicableUnknownNCT04966416
What this trial is testing

Calcinosis Reduction by Pyrophosphate in SSC

Who this might be right for
Systemic SclerosisScleroderma
Szeged University 60
Testing effectiveness (Phase 2)Ended earlyNCT02558543
What this trial is testing

Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Assistance Publique Hopitaux De Marseille 40
Testing effectiveness (Phase 2)Study completedNCT03120533
What this trial is testing

Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study

Who this might be right for
Scleroderma, Systemic
University Hospital, Grenoble 18
Early research (Phase 1)Looking for participantsNCT07305116
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Next Page